[144] Doximity, Inc. SEC Filing

Rhea-AI Filing Summary

Doximity, Inc. (DOCS) Form 144 notice: An insider proposes to sell 2,000 common shares through Morgan Stanley Smith Barney on 09/02/2025 on the NYSE, with an aggregate market value of $133,140.00. The securities were acquired the same day via a stock option exercise and paid in cash. The filer previously sold 2,000 shares on 08/01/2025 for $114,180.00 and 2,000 shares on 07/01/2025 for $121,920.00. The filing includes the required representation that the seller does not possess undisclosed material adverse information.

Positive

• Disclosure compliance: The filer submitted a Form 144 showing planned sale details as required under Rule 144.
• Transaction transparency: The filing specifies acquisition method (stock option exercise), payment in cash, broker, sale date, and aggregate market value.

Negative

• Insider selling: The person sold 2,000 shares in July and 2,000 shares in August 2025 and plans to sell an additional 2,000 shares on 09/02/2025.
• No 10b5-1 plan date disclosed: The filing does not state a trading-plan adoption date or reliance on Rule 10b5-1.

Insights

Securities Analyst

TL;DR: Insider exercised options and is selling 2,000 shares on 09/02/2025 after selling 4,000 shares in prior months.

The Form 144 documents a routine sale of shares that were acquired by exercise of stock options on 09/02/2025, with the planned transaction executed through Morgan Stanley Smith Barney on the NYSE. The filing confirms cash payment for the exercise and lists prior open-market sales of 2,000 shares in July and 2,000 shares in August 2025, including gross proceeds. From a compliance perspective this is a standard Rule 144 notification ensuring the seller meets public-sale notice requirements; it contains no details of trading plans or 10b5-1 adoption dates.

Corporate Governance Expert

TL;DR: This is a procedural disclosure showing insider liquidity events, not a disclosure of new material company information.

The document provides clear record of an insider liquidity event: a same-day option exercise and intended sale of 2,000 shares. The filing includes the sellers attestation about absence of undisclosed material adverse information. The absence of a stated Rule 10b5-1 plan adoption date means no explicit reliance on an affirmative written trading plan is disclosed in this notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	133140.00	187299459	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Stock Option Exercise	Issuer			2000	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	08/01/2025	2000	114180.00
KIRA WAMPLER 500 3rd Street Ste 510 San Francisco CA 94107	Common	07/01/2025	2000	121920.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Doximity (DOCS) Form 144 filed here report?

It reports a proposed sale of 2,000 common shares to be executed through Morgan Stanley Smith Barney on 09/02/2025 with aggregate market value of $133,140.00.

How were the shares being sold acquired?

The 2,000 shares were acquired on 09/02/2025 by stock option exercise, with payment made in cash on the same date.

Has the insider sold other DOCS shares recently?

Yes. The filer sold 2,000 shares on 08/01/2025 for $114,180.00 and 2,000 shares on 07/01/2025 for $121,920.00.

Which broker will handle the sale?

The sale is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, New York, NY.

Does the Form 144 indicate the seller has undisclosed material information?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.